Results 131 to 140 of about 2,547 (172)

Drug-Coated Balloons and Bioresorbable Scaffolds in Spontaneous Coronary Artery Dissections. [PDF]

J Clin Med
Sagris M, Bantidos MG, Stalikas N, Fyntanidou B, Kofos C, Tsioufis K, Karagiannidis E, Patsourakos N.   +7 more
europepmc   +1 more source

Early "Scars" and Long-Term Promise of Bioresorbable Scaffolds: A Decade of Evidence From SCAAR. [PDF]

J Soc Cardiovasc Angiogr Interv
Singh J, George PM, Stone GW.
europepmc   +1 more source

Outcomes of durable versus biodegradable polymer drug-eluting stents in patients with coronary artery disease. [PDF]

Int J Cardiol Heart Vasc
Skos C, Rogozarski J, Dizdarevic AM, M Steiner-Gager G, Postula M, Eyileten C, Toma A, Speidl WS, Skoro-Sajer N, Gerges C, Lang IM, Siller-Matula JM.   +11 more
europepmc   +1 more source

Evaluation of Ultrasonic Spray Method for Application of Sirolimus-Eluting Coating on Bioresorbable Vascular Scaffolds. [PDF]

Int J Mol Sci
Jelonek K, Jaworska J, Musiał-Kulik M, Stojko M, Włodarczyk J, Sobota M, Pastusiak M, Smola-Dmochowska A, Szewczenko J, Goldsztajn K, Dobrzyński P, Kasperczyk J.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Bioresorbable stents: Is the game over?

International Journal of Cardiology, 2022
Bioresorbable scaffolds (BRS) emerged as an alternative to conventional stents with a fundamental idea, to avoid a permanent metallic cage with all its harmful effects on the vessel. The Absorb BVS was the first widely studied device with the promising concept of performing a percutaneous coronary intervention, giving the necessary initial support to ...
Gallinoro E., Almendarez M., Alvarez-Velasco R., Barbato E., Avanzas P.   +4 more
openaire   +2 more sources

Bioresorbable scaffolds for the treatment of in-stent restenosis

Heart and Vessels, 2014
Percutaneous coronary intervention with bare-metal stents or drug-eluting stents can decrease clinical event rates compared with simple balloon angioplasty. However, stent implantation is often associated with subsequent restenosis. Bioresorbable coronary scaffolds provide short-term vessel scaffolding with drug delivery capability and are designed to ...
Oliver Dorr, Christoph Liebetrau, Jens Wiebe   +2 more
exaly   +3 more sources

Bioresorbable Stents in PCI

Current Cardiology Reports, 2016
The evolution of percutaneous coronary intervention has been considerable. Coronary stents were introduced to avoid vessel recoil and reduce acute and late vessel complications. Later, drug-eluting stents were developed to decrease the neointimal hyperplasia associated with bare metal stents in order to reduce restenosis.
Daniel, Lindholm, Stefan, James
openaire   +2 more sources

Bioresorbable stents: Current and upcoming bioresorbable technologies

International Journal of Cardiology, 2017
Bioresorbable scaffolds (BRS) represent a novel horizon in interventional cardiology for the treatment of coronary artery disease. The technology was introduced to overcome limitations of current metallic drug-eluting stents such as late in-stent restenosis and permanently caging the vessel.
Hui Ying, Ang, Heerajnarain, Bulluck, Philip, Wong, Subbu S, Venkatraman, Yingying, Huang, Nicolas, Foin   +5 more
openaire   +2 more sources

A bioresorbable urethral stent

Urological Research, 1993
The aim of the present study was to examine the suitability of biodegradable polymers as materials for a urethral stent. A new urethral stent made of biodegradable self-reinforced poly-L-lactide (SR-PLLA) was implanted in 16 male rabbits after urethrotomy. Seven stents of stainless steel served as controls.
E, Kemppainen, M, Talja, M, Riihelä, T, Pohjonen, P, Törmälä, O, Alfthan   +5 more
openaire   +2 more sources

Stent Thrombosis With Drug-Eluting Stents and Bioresorbable Scaffolds

JACC: Cardiovascular Interventions, 2016
Si-Hyuck Kang, In-Ho Chae, Jin-Joo Park   +2 more
exaly   +2 more sources